Théophile Ohlmann PhD Biochemistry, HDR-Team Leader at the CIRI (Lyon)

Course and current status

Since 2008              Research Director Inserm (DR2)

2006                       Team Leader at the ENS de Lyon, U 758

2003

CR 1 Inserm and HDR, Diploma to enable research supervision (Univ.Lyon I)

1999-2003

CR 2 Inserm (unité 412, ENS-Lyon)

1998-1999

Post-doc. at ENS (Lyon) with  Pr. J-L Darlix

1996-1998

Post doc at the University of Cambridge (England) with Pr. RJ.Jackson

1993-1996

PhD at the University of Sussex (England) under the supervision of Pr. VM. Pain.

1989-1993

Master in cell biology (Univ. Grenoble I)

Scientific summary

1- Scientific Delegate for the HCERES (2016- ) 

2-Member of the conseil scientifique of the Doctoral School BMIC (2016-2021)

3-Reviewing

Journals

Nature, PNAS, RNA, Nucleic Acid Research (Methods and Articles), Journal of Biological Chemistry, Biochemical Journal, Molecular and Cellular Biology, Oncogene, Biochemistry, PLos One, Bio-essay, BMC bioinformatics, BMC evolutionary biology, Biochemica Biophysica Acta sinica, Biochimie, Biotechniques, Translation, Virology, Viruses, J.Gen.Virol, Retrovirology, Virologie, Virus Research.

Grants

FNRS (Belgique), FNS (Suisse), FWF (Autriche), Peter Marsden Fund (New Zealand), National Science Fundation (USA), Wellcome Trust (UK), BBSRC (UK), Fondation pour la recherche médicale (Fr), Ligue contre le cancer (Fr), Agence Nationale pour la Recherche (Fr) (Programmes blancs et jeunes chercheurs), AERES (Fr), Université Paris Descartes (Fr), Université Pierre et Marie Curie (Fr), Université Sorbonne Paris Cité (Fr.), University of Southampton (UK), Idex Paris Ile de France (Fr.), University of Surrey (UK). 

 


Image d’exemple